Patrick Nachman
University of Minnesota, Department of Medicine, Division of Renal Diseases and Hypertension
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick Nachman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:33 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03949855 · Belimumab With Rituximab for Primary Membranous NephropathyNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Membranous Nephropathy, Nephrotic Syndrome · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & EthicsU01DK133097 · NIDDK · UNIVERSITY OF MINNESOTA · fiscal years 2022 to 2026 · $452,262 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:33 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.J Am Soc Nephrol · 1996255 citationsRCR 8.8
- Mycophenolate mofetil therapy in lupus nephritis: clinical observations.J Am Soc Nephrol · 1999190 citationsRCR 6.0
- Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.Ann Rheum Dis · 2023109 citationsRCR 13.9
- Long-term glycemic control measurements in diabetic patients receiving hemodialysis.Am J Kidney Dis · 2002102 citationsRCR 2.7